BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 28256910)

  • 21. Id-1 promotes osteosarcoma cell growth and inhibits cell apoptosis via PI3K/AKT signaling pathway.
    Hao L; Liao Q; Tang Q; Deng H; Chen L
    Biochem Biophys Res Commun; 2016 Feb; 470(3):643-649. PubMed ID: 26797271
    [TBL] [Abstract][Full Text] [Related]  

  • 22. miR-92a promotes tumor growth of osteosarcoma by targeting PTEN/AKT signaling pathway.
    Xiao J; Yu W; Hu K; Li M; Chen J; Li Z
    Oncol Rep; 2017 Apr; 37(4):2513-2521. PubMed ID: 28260104
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MiR-100 Inhibits Osteosarcoma Cell Proliferation, Migration, and Invasion and Enhances Chemosensitivity by Targeting IGFIR.
    Liu Y; Zhu ST; Wang X; Deng J; Li WH; Zhang P; Liu BS
    Technol Cancer Res Treat; 2016 Oct; 15(5):NP40-8. PubMed ID: 26306402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential Molecular Mechanisms of AURKB in the Oncogenesis and Progression of Osteosarcoma Cells: A Label-Free Quantitative Proteomics Analysis.
    Pi WS; Cao ZY; Liu JM; Peng AF; Chen WZ; Chen JW; Huang SH; Liu ZL
    Technol Cancer Res Treat; 2018; 18():1533033819853262. PubMed ID: 31122179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Down-Regulation of Ubiquitin-Specific Peptidase 9X Inhibited Proliferation, Migration and Invasion of Osteosarcoma via ERK1/2 and PI3K/Akt Signaling Pathways.
    Zheng W; Li S; Huang J; Dong Y; Zhang H; Zheng J
    Biol Pharm Bull; 2022; 45(9):1283-1290. PubMed ID: 36047196
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isoliquiritigenin Suppresses Osteosarcoma U2OS Cell Proliferation and Invasion by Regulating the PI3K/Akt Signalling Pathway.
    Chen J; Liu C; Yang QQ; Ma RB; Ke Y; Dong F; Wu XE
    Chemotherapy; 2018; 63(3):155-161. PubMed ID: 29936511
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tizanidine hydrochloride exhibits a cytotoxic effect on osteosarcoma cells through the PI3K/AKT signaling pathway.
    Xing XW; Sun YF; Zhao J; Pan ZX; Jiang WX
    J Int Med Res; 2019 Aug; 47(8):3792-3802. PubMed ID: 31179788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LncRNA-p21 inhibited the proliferation of osteosarcoma cells via the miR-130b/PTEN/AKT signaling pathway.
    Han W; Liu J
    Biomed Pharmacother; 2018 Jan; 97():911-918. PubMed ID: 29136769
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overexpression of FER1L4 promotes the apoptosis and suppresses epithelial-mesenchymal transition and stemness markers via activating PI3K/AKT signaling pathway in osteosarcoma cells.
    Ma L; Zhang L; Guo A; Liu LC; Yu F; Diao N; Xu C; Wang D
    Pathol Res Pract; 2019 Jun; 215(6):152412. PubMed ID: 31000382
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SLC3A2 is upregulated in human osteosarcoma and promotes tumor growth through the PI3K/Akt signaling pathway.
    Zhu B; Cheng D; Hou L; Zhou S; Ying T; Yang Q
    Oncol Rep; 2017 May; 37(5):2575-2582. PubMed ID: 28350098
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lapatinib alters the malignant phenotype of osteosarcoma cells via downregulation of the activity of the HER2-PI3K/AKT-FASN axis in vitro.
    Long XH; Zhang GM; Peng AF; Luo QF; Zhang L; Wen HC; Zhou RP; Gao S; Zhou Y; Liu ZL
    Oncol Rep; 2014 Jan; 31(1):328-34. PubMed ID: 24172910
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiR-9 is overexpressed in spontaneous canine osteosarcoma and promotes a metastatic phenotype including invasion and migration in osteoblasts and osteosarcoma cell lines.
    Fenger JM; Roberts RD; Iwenofu OH; Bear MD; Zhang X; Couto JI; Modiano JF; Kisseberth WC; London CA
    BMC Cancer; 2016 Oct; 16(1):784. PubMed ID: 27724924
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PENK inhibits osteosarcoma cell migration by activating the PI3K/Akt signaling pathway.
    Zhang HP; Yu ZL; Wu BB; Sun FR
    J Orthop Surg Res; 2020 Apr; 15(1):162. PubMed ID: 32334633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of X-Box Binding Protein 1 (XBP1) Correlates to Poor Prognosis and Up-Regulation of PI3K/mTOR in Human Osteosarcoma.
    Yang J; Cheng D; Zhou S; Zhu B; Hu T; Yang Q
    Int J Mol Sci; 2015 Dec; 16(12):28635-46. PubMed ID: 26633383
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GPNMB silencing suppresses the proliferation and metastasis of osteosarcoma cells by blocking the PI3K/Akt/mTOR signaling pathway.
    Jin R; Jin YY; Tang YL; Yang HJ; Zhou XQ; Lei Z
    Oncol Rep; 2018 Jun; 39(6):3034-3040. PubMed ID: 29620278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-187 Inhibits Growth and Metastasis of Osteosarcoma by Downregulating S100A4.
    Xiao Y; Zhao Q; Du B; Chen HY; Zhou DZ
    Cancer Invest; 2018 Jan; 36(1):1-9. PubMed ID: 29303365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Knockdown of pyruvate kinase type M2 suppresses tumor survival and invasion in osteosarcoma cells both in vitro and in vivo.
    Yuan Q; Yu H; Chen J; Song X; Sun L
    Exp Cell Res; 2018 Jan; 362(1):209-216. PubMed ID: 29155364
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MiR-451 suppresses proliferation, migration and promotes apoptosis of the human osteosarcoma by targeting macrophage migration inhibitory factor.
    Liu W; Liu SY; He YB; Huang RL; Deng SY; Ni GX; Yu B
    Biomed Pharmacother; 2017 Mar; 87():621-627. PubMed ID: 28086136
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adenovirus-mediated overexpression of BMP-9 inhibits human osteosarcoma cell growth and migration through downregulation of the PI3K/AKT pathway.
    Li B; Yang Y; Jiang S; Ni B; Chen K; Jiang L
    Int J Oncol; 2012 Nov; 41(5):1809-19. PubMed ID: 22948234
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Knockdown of UBE2T Inhibits Osteosarcoma Cell Proliferation, Migration, and Invasion by Suppressing the PI3K/Akt Signaling Pathway.
    Wang Y; Leng H; Chen H; Wang L; Jiang N; Huo X; Yu B
    Oncol Res; 2016; 24(5):361-369. PubMed ID: 27712593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.